Preclinical Animal Behaviour Market: USD 27.61 Million Growth Forecasted at a CAGR of 5.03% between 2024 to 2028 - Technavio [Yahoo! Finance]
Harvard Bioscience, Inc. (HBIO)
Last harvard bioscience, inc. earnings: 2/26 07:15 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.harvardbioscience.com
Company Research
Source: Yahoo! Finance
USD 27.61 million at an impressive CAGR of 5.03% between 2023 and 2028. The surge in global disease prevalence, including cardiovascular diseases, metabolic disorders, and cancer, is fuelling the demand for innovative therapeutics. This has led to increased preclinical and clinical research activities by pharmaceutical companies and Contract Research Organizations (CROs). Omics-based technologies such as genomics, proteomics, and metabolomics have gained attention, attracting investments for drug development projects. The intense competition in drug development has prompted the need for sophisticated animal behaviour monitoring equipment in preclinical research. For a better understanding of market dynamics and trends, download the free sample report Regulatory Challenges and Market Segmentation The preclinical animal behaviour market is projected to grow rapidly due to stricter regulations for pharmaceutical safety and increased funding for research in neuroscience, cardiology, met
Show less
Read more
Impact Snapshot
Event Time:
HBIO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HBIO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HBIO alerts
High impacting Harvard Bioscience, Inc. news events
Weekly update
A roundup of the hottest topics
HBIO
News
- Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ETGlobeNewswire
- Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth [Yahoo! Finance]Yahoo! Finance
- Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in GrowthGlobeNewswire
- Harvard Apparatus Regenerative Technology Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights [Yahoo! Finance]Yahoo! Finance
- Investing in Harvard Bioscience (NASDAQ:HBIO) a year ago would have delivered you a 25% gain [Yahoo! Finance]Yahoo! Finance
HBIO
Earnings
- 3/7/24 - Beat
HBIO
Sec Filings
- 4/3/24 - Form ARS
- 4/3/24 - Form DEFA14A
- 4/3/24 - Form DEF
- HBIO's page on the SEC website